Skip to main content
Log in

“Mild” vs. “long” protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Background

This large prospective, randomized study was designed to compare the “mild” protocol with clomiphene citrate, low-dose gonadotropins and a GnRH-antagonist (CC/Gn/GnRH-ant protocol) with the “long” protocol with a GnRH-agonist and high-dose Gn for the controlled ovarian hyperstimulation (COH) of patients with expected poor ovarian responsiveness undergoing IVF.

Materials and Methods

A total of 695 women with clinical, endocrine and ultrasound characteristics suggesting a low ovarian reserve and a poor responsiveness to COH were recruited and randomly assigned to receive the CC/Gn/GnRH-ant “mild” protocol (mild group, n = 355) or the “long” protocol with high-dose Gn (long group, n = 340).

Results

The “mild” stimulation led to significantly shorter follicular phase, lower consumption of exogenous Gn and lower peak estradiol level than the “long” regimen. With the “long” protocol, significantly less cycles were cancelled due to the lack of ovarian response; further, it obtained significantly more oocytes, more mature oocytes, more embryos, and a thicker endometrium. As for the final IVF outcome, however, the two stimulation regimens obtained comparable implantation rate, clinical pregnancy rate, and ongoing pregnancy rate at 12 weeks.

Conclusions

In conclusion, the “mild” CC/Gn/GnRH-ant stimulation protocol is a valid alternative to the long protocol with high Gn dose as it obtains a comparable success rate and requires significantly less medications, with an obvious economical advantage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Domingues TS, Rocha AM, Serafini PC. Tests for ovarian reserve: reliability and utility. Curr Opin Obstet Gynecol. 2010;22:271–6.

    PubMed  Google Scholar 

  2. Kyrou D, Kolibianakis EM, Venetis CA, Papanikolau EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2009;91:749–66.

    Article  CAS  PubMed  Google Scholar 

  3. Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL. The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update. 2012;18:1–11.

    Article  CAS  PubMed  Google Scholar 

  4. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, Mc Tavish AR. Interventions for “poor responders” to controlled ovarian hyperstimulation (COH) in in vitro fertilization (IVF). Cochrane Database Syst Rev. 2007;24, CD004379.

    Google Scholar 

  5. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF : a systematic review. Hum Reprod Update. 2003;9:61–76.

    Article  CAS  PubMed  Google Scholar 

  6. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril. 1996;65:961–5.

    CAS  PubMed  Google Scholar 

  7. Lekamge DN, Lane M, Gilchrist RB, Tremellen KP. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve. J Assist Reprod Genet. 2008;25:515–21.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008;89:1694–701.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Nargund J, Fauser BCJM, Macklon NS, Ombelet W, Nygren K, Frydman R. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod. 2007;11:2801–4.

    Article  Google Scholar 

  10. Verberg MF, Macklon NS, Nargund G, Frydman R, Devroey P, Broekmans FJ, et al. Mild ovarian stimulation for IVF. Hum Reprod Update. 2009;15:13–29.

    Article  CAS  PubMed  Google Scholar 

  11. Revelli A, Casano S, Salvagno F, Delle PL. Milder is better? Advantages and disadvantages of “mild” ovarian stimulation for human in vitro fertilization. Reprod Biol Endocrinol. 2011;16:9–25.

    Google Scholar 

  12. Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered “difficult responders” to GnRH protocols? Hum Reprod. 1999;14:2959–62.

    Article  CAS  PubMed  Google Scholar 

  13. Takahashi K, Mukaida T, Tomiyana T, Goto T, Oka C. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol. J Assist Reprod Genet. 2004;21:317–22.

    Article  PubMed Central  PubMed  Google Scholar 

  14. D’Amato G, Caroppo E, Pasquadibisceglie A, Carone D, Vitti A, Vizziello GM. A novel protocol of ovulation induction with delayed gonadotrophin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril. 2004;81:1572–7.

    Article  PubMed  Google Scholar 

  15. Holte J, Berglund L, Milton K, Garello C, Gennarelli G, Revelli A, et al. Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of embryos scored and transferred on day 2 after oocyte retrieval. Hum Reprod. 2007;22:548–57.

    Article  CAS  PubMed  Google Scholar 

  16. Quigley MM, Schmidt CL, Beauchamp PJ, Maklad NF, Berkowitz AS, Wolf DP. Preliminary experience with a combination of clomiphene and variable dosages of menopausal gonadotropins for enhanced follicular recruitment. J In Vitro Fertil Embryol Transf. 1985;2:11–6.

    Article  CAS  Google Scholar 

  17. Hwang JL, Huang LW, Hsieh BC, Tsai YL, Huang SC, Chen CY, et al. Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles. Hum Reprod. 2003;18:45–9.

    Article  CAS  PubMed  Google Scholar 

  18. Adashi EY. Clomiphene Citrate: mechanisms and sites of action- a hypothesis revisited. Fertil Steril. 1984;42:331–43.

    CAS  PubMed  Google Scholar 

  19. Figueiredo JB, Nastri CO, Vieira AD, Martins WP. Clomiphene combined with gonadotropins and GnRH antagonist versus conventional controlled ovarian hyperstimulation without clomiphene in women undergoing assisted reproductive techniques: systematic review and meta-analysis. Arch Gynecol Obstet. 2013;287:779–90.

    Article  CAS  PubMed  Google Scholar 

  20. Gibreel A, Maheshwari A, Bhattacharya S. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization. Cochrane Database Syst Rev. 2012;11, CD008528.

    PubMed  Google Scholar 

  21. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–24.

    Article  CAS  PubMed  Google Scholar 

  22. Mochtar MH, Van der Veen A, Ziech M, van Wely M. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2007;18, CD005070.

    Google Scholar 

  23. Yanaihara A, Yorimitsu T, Motoyama H, Ohara M, Kawamura T. The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome. J Assist Reprod Genet. 2008;25:115–8.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Lin YH, Hwang JL, Seow KM, Huang LW, Hsieh BC, Tzeng CR. Comparison of outcome of clomiphene citrate/human menopausal gonadotropine/cetrorelix protocol and buserelin long protocol- a randomized study. Gynecol Endocrinol. 2006;22:297–302.

    Article  PubMed  Google Scholar 

  25. Gougeon A. Regulation of ovarian follicular development in primates: facts and ypotheses. Endocr Rev. 1996;17:121–55.

    Article  CAS  PubMed  Google Scholar 

  26. Check JH, Summers-Chase D, Yuan W, Horwath D, Wilson C. Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve. Fertil Steril. 2007;87:749–56.

    Article  PubMed  Google Scholar 

Download references

Competing interests

The authors declare that they have no competing interests.

Authors’ contribution

AC, VS, FE and GB collected the data. AC provided the first draft of the manuscript. PD performed the statistical analysis. AR conceived the study, participated in its design and coordination, and helped to draft the manuscript. CB provided critical revision of the manuscript. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alberto Revelli.

Additional information

Capsule

“Mild” stimulation protocol for expected poor responders.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 226 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Revelli, A., Chiadò, A., Dalmasso, P. et al. “Mild” vs. “long” protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial. J Assist Reprod Genet 31, 809–815 (2014). https://doi.org/10.1007/s10815-014-0227-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-014-0227-y

Keywords

Navigation